Commitments

Xilinx leases some of its facilities and office buildings under non-cancelable operating leases that expire at various dates through October 2021. Additionally, Xilinx entered into a land lease in conjunction with the Company's building in Singapore, which will expire in November 2035 and the lease cost was settled in an up-front payment in June 2006. Some of the operating leases for facilities and office buildings require payment of operating costs, including property taxes, repairs, maintenance and insurance. Most of the Company's leases contain renewal options for varying terms. Approximate future minimum lease payments under non-cancelable operating leases are as follows:



Fiscal	(In thousands)
2017	$	5,106
2018	3,138
2019	2,885
2020	2,078
2021	1,494
Thereafter	956
Total	$	15,657

Aggregate future rental income to be received, which includes rents from both owned and leased property, totaled $2.7 million as of April 2, 2016. Rent expense, net of rental income, under all operating leases was $4.5 million for fiscal 2016, $3.2 million for fiscal 2015, and $3.1 million for fiscal 2014. Rental income was not material for fiscal 2016, 2015 or 2014.

Other commitments as of April 2, 2016 totaled $108.9 million and consisted of purchases of inventory and other non-cancelable purchase obligations related to subcontractors that manufacture silicon wafers and provide assembly and test services. The Company expects to receive and pay for these materials and services in the next three to six months, as the products meet delivery and quality specifications. As of April 2, 2016, the Company had $33.8 million of non-cancelable license obligations to providers of electronic design automation software and hardware/software maintenance expiring at various dates through December 2018. As of April 2, 2016, the Company also had open purchase obligations totaling $15.0 million related to the renovation of one of its properties. The Company expects to receive and pay for these materials and services within the next six months.